In addition, in the neurotrophin signaling pathway, it has been reported that the expression of gene PSEN1 is significantly decreased in schizophrenia and bipolar patient groups, supporting PSEN1 as a potential biomarker for both diseases48. This evidence concerns the gene BDNF and schizophrenia.